Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1033964.
Observations1
Issue DateApril 19, 2024
StatusNo Warning Letter
Related Inspections9
Establishment Details
Firm
GlaxoSmithKline LLC
Location
Zebulon, North Carolina, United States
FEI Number
1033964
Product Type
Drugs
Issue Date
April 19, 2024
Country
United States
Inspection History, 2009 to 2026
NAI7
VAI2
NAI means No Action Indicated. VAI means Voluntary Action Indicated.
Talk to a Specialist